scispace - formally typeset
H

Hans-Peter Lenhof

Researcher at Saarland University

Publications -  170
Citations -  6982

Hans-Peter Lenhof is an academic researcher from Saarland University. The author has contributed to research in topics: Cancer & Macromolecular docking. The author has an hindex of 44, co-authored 164 publications receiving 6046 citations. Previous affiliations of Hans-Peter Lenhof include Max Planck Society.

Papers
More filters
Journal ArticleDOI

Integrative analysis of cancer-related data using CAP

TL;DR: The cancer‐associated protein database (CAP) is presented, a novel analysis system for cancer‐related data that integrates data from multiple external databases, augments these data with functional annotations, and offers tools for statistical analysis of these data.
Journal ArticleDOI

Rapid software prototyping in molecular modeling using the biochemical algorithms library (BALL)

TL;DR: BALL is designed and implemented, the first object-oriented application framework for rapid prototyping in Molecular Modeling, and provides fundamental components for import/export of data in various file formats, Molecular Mechanics simulations, three-dimensional visualization, and more complex ones like a numerical solver for the Poisson-Boltzmann equation.
Journal ArticleDOI

REGGAE: a novel approach for the identification of key transcriptional regulators.

TL;DR: REGGAE uses a Kolmogorov‐Smirnov‐like test statistic that implicitly combines associations between regulators and their target genes with an enrichment approach to prioritize the influence of transcriptional regulators and is a valuable tool for the elucidation of complex regulatory mechanisms.
Journal ArticleDOI

SePaCS—a web-based application for classification of seroreactivity profiles

TL;DR: A web-based application that enables clinical groups to carry out analyzes of training sets and predictions of unclassified seroreactivity profiles with minimal effort is developed, called SePaCS, which provides a broad range of classification methods.
Journal ArticleDOI

Paired proteomics, transcriptomics and miRNomics in non-small cell lung cancers: known and novel signaling cascades

TL;DR: The resulting interaction network, which is based on quantitative analysis of the abundance of miRNAs, mRNAs and proteins each taken from the same lung cancer tissue and from theSame autologous normal lung tissue confirms molecular pathological changes and further contributes to the discovery of altered signaling cascades in lung cancer.